How we review

Before publication

1. Question first. Every piece begins as a question a real patient asked, not as a keyword. If we cannot state the question in one sentence, we do not commission the piece.
2. Primary sources read in full. Trials are read as published papers, including supplementary appendices, not as abstracts and not as news coverage.
3. Numbers checked twice. Every figure that appears in the text is checked against its source by someone who did not write the sentence.
4. Clinical review. Dr. Nick Robertson, MD, reviews any article containing dosing, safety, or treatment guidance and signs it with a date.
5. Conflict check. We confirm that no company mentioned has any financial relationship with the publication. To date, none ever has.
6. Plain-language pass. A final edit removes jargon that carries no information, and restores the hedges that matter.

After publication

Evergreen guides are re-checked every six months, and immediately whenever the FDA changes a label, a major trial reports, or a supply or pricing situation shifts materially. The review date shown on the article is the date of the most recent check.

News articles are not retrospectively rewritten. When a story develops, we publish a new piece and link the two, so the record of what was known and when remains intact.

What a review date means

A review date tells you a physician read the clinical content on that date and confirmed it still reflects the evidence as they understood it. It does not mean the article is exhaustive, and it does not mean it applies to you. Only your own clinician can tell you that.